Autoimmune disorders associated with common variable immunodeficiency: prediction, diagnosis, and treatment

References

• Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93(3):190–197.
   PubMed Web of Science ®Google Scholar
• Shillitoe B, Bangs C, Guzman D, et al. The United Kingdom primary immune deficiency (UKPID) registry 2012 to 2017. Clinical and Experimental Immunology. 2018;192(3):284–291.
   PubMed Web of Science ®Google Scholar
• CEREDIH: The French PID Study Group. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135(2):264–272.
   PubMed Web of Science ®Google Scholar
• Lopes JP, Cunningham-Rundles CJI, Clinics A. The importance of primary immune deficiency registries: the United States immunodeficiency network registry. Immunology and Allergy Clinics of North America. 2020;40(3):385–402.
   PubMed Web of Science ®Google Scholar
• El-Helou SM, Biegner A-K, Bode S, et al. The German national registry of primary immunodeficiencies (2012–2017). Frontiers in Immunology. 2019;10:1272.
   PubMed Web of Science ®Google Scholar
• Al-Mousa H, BJFii A-S. Primary immunodeficiency diseases in highly consanguineous populations from Middle East and North Africa: epidemiology, diagnosis, and care. Frontiers in Immunology. 2017;8:678.
   PubMed Web of Science ®Google Scholar
• Mellouli F, Mustapha IB, Khaled MB, et al. Report of the Tunisian registry of primary immunodeficiencies: 25-years of experience (1988–2012). J Clin Immunol. 2015;35(8):745–753.
   PubMed Web of Science ®Google Scholar
• Modell V, Orange JS, Quinn J, et al. Global report on primary immunodeficiencies: 2018 update from the Jeffrey modell centers network on disease classification, regional trends, treatment modalities, and physician reported outcomes. Immunol Res. 2018;66(3):367–380.
   PubMed Web of Science ®Google Scholar
• Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277–286.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Ann Allergy Asthma Immunol. 2019;123(5):454–460.
   PubMed Web of Science ®Google Scholar
• Schroeder HW, Schroeder HW, Sheikh SM. The complex genetics of common variable immunodeficiency. J Invest Med. 2004;52(2):90.
   PubMed Web of Science ®Google Scholar
• Bonilla FA, Barlan I, Chapel H, et al. International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol. 2016;4(1):38–59.
   Web of Science ®Google Scholar
• Abolhassani H, Aghamohammadi A, Fang M, et al. Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 2019;21(1):243–251.
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34–48.
   PubMed Web of Science ®Google Scholar
• Oksenhendler E, Gérard L, Fieschi C, et al. Infections in 252 patients with common variable immunodeficiency. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. 2008;46(10):1547–1554.
   PubMed Web of Science ®Google Scholar
• Bates CA, Ellison MC, Lynch DA, et al. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. The Journal of Allergy and Clinical Immunology. 2004;114(2):415–421.
   PubMed Web of Science ®Google Scholar
• Ardeniz O, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol. 2009;133(2):198–207.
   PubMed Web of Science ®Google Scholar
• Wehr C, Kivioja T, Schmitt C, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77–85.
   PubMed Web of Science ®Google Scholar
• Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. Journal of Clinical Immunology. 2007;27(3):308–316.
   PubMed Web of Science ®Google Scholar
• Ballow M. Primary immunodeficiency disorders: antibody deficiency. J Allergy Clin Immunol. 2002;109(4):581–591.
   PubMed Web of Science ®Google Scholar
• Ameratunga R, Allan C, S-TJI W, et al. Defining common variable immunodeficiency disorders in 2020. Immunology and Allergy Clinics of North America. 2020;40(3):403–420.
   PubMed Web of Science ®Google Scholar
• Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol. 2006;117(4):740–746.
   PubMed Web of Science ®Google Scholar
• Ochtrop ML, Goldacker S, May AM, et al. T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency. Blood. 2011;118(2):309–318.
   PubMed Web of Science ®Google Scholar
• Herbst E, Armbruster M, Rump J, et al. Intestinal B cell defects in common variable immunodeficiency. Clinical and Experimental Immunology. 1994;95(2):215–221.
   PubMed Web of Science ®Google Scholar
• Taubenheim N, von Hornung M, Durandy A, et al. Defined blocks in terminal plasma cell differentiation of common variable immunodeficiency patients. Journal of Immunology (Baltimore, Md. : 1950). 2005;175(8):5498–5503.
   PubMed Web of Science ®Google Scholar
• Baldovino S, Montin D, Martino S, et al. Common variable immunodeficiency: crossroads between infections, inflammation and autoimmunity. Autoimmun Rev. 2013;12(8):796–801.
   PubMed Web of Science ®Google Scholar
• Christiansen M, Offersen R, Jensen JMB, et al., Identification of Novel Genetic Variants in CVID Patients With Autoimmunity. Autoinflam Malignan. 2020. 10(3022)
   Google Scholar
• Shavit R, Maoz-Segal R, Frizinsky S, et al. Combined immunodeficiency (CVID and CD4 lymphopenia) is associated with a high risk of malignancy among adults with primary immune deficiency. Clin Exp Immunol. 2021;204(2):251–257.
   PubMed Web of Science ®Google Scholar
• Lopez-Herrera G, Tampella G, Pan-Hammarström Q, et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. American Journal of Human Genetics. 2012;90(6):986–1001.
   PubMed Web of Science ®Google Scholar
• Bonhomme D, Hammarström L, Webster D, et al. Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Iimmunol. 2000;165(8):4725–4730. Baltimore, Md: 1950.
   PubMed Web of Science ®Google Scholar
• Brouet J-C, Chedeville A, Fermand J-P, et al. Study of the B cell memory compartment in common variable immunodeficiency. Eur J Immunol. 2000;30(9):2516–2520.
   PubMed Web of Science ®Google Scholar
• Andersen P, Permin H, Andersen V, et al. Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency. Blood. 2005;105(2):511–517.
   PubMed Web of Science ®Google Scholar
• Warnatz K, Denz A, Dräger R, et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002;99(5):1544–1551.
   PubMed Web of Science ®Google Scholar
• Groth C, Drager R, Warnatz K, et al. Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol. 2002;129(1):133–139.
   PubMed Web of Science ®Google Scholar
• Troilo A, Wehr C, Janowska I, et al. Nonpermissive bone marrow environment impairs early B-cell development in common variable immunodeficiency. Blood. 2020;135(17):1452–1457.
   PubMed Web of Science ®Google Scholar
• Carsetti R, Rosado MM, Donnanno S, et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol. 2005;115(2):412–417.
   PubMed Web of Science ®Google Scholar
• Jacquot S, Maçon-Lemaître L, Paris E, et al. B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients. Int Immunol. 2001;13(7):871–876.
   PubMed Web of Science ®Google Scholar
• Levy Y, Gupta N, Le Deist F, et al. Defect in IgV gene somatic hypermutation in common variable immuno-deficiency syndrome. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(22):13135–13140.
   PubMed Web of Science ®Google Scholar
• Piqueras B, Lavenu-Bombled C, Galicier L, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. Journal of Clinical Immunology. 2003;23(5):385–400.
   PubMed Web of Science ®Google Scholar
• Berglund LJ, Wong SWJ, Fulcher DA. B-cell maturation defects in common variable immunodeficiency and association with clinical features. Pathology. 2008;40(3):288–294.
   PubMed Web of Science ®Google Scholar
• Yazdani R, Seify R, Ganjalikhani-Hakemi M, et al. Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets. Allergol Immunopathol (Madr). 2017;45(2):183–192.
   PubMed Web of Science ®Google Scholar
• Ferry BL, Jones J, Bateman EA, et al. Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method. Clin Exp Immunol. 2005;140(3):532–539.
   PubMed Web of Science ®Google Scholar
• Cherukuri A, Cheng PC, Pierce Skjtjo I. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. Journal of Immunology (Baltimore, Md. : 1950). 2001;167(1):163–172.
   PubMed Web of Science ®Google Scholar
• Fischer E, Delibrias C, MJTJoi K. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 1991;146(3):865–869.
   PubMed Web of Science ®Google Scholar
• Thorarinsdottir K, Camponeschi A, Gjertsson I, et al. CD 21−/low B cells: a snapshot of a unique B cell subset in health and disease. Scandinavian Journal of Immunology. 2015;82(3):254–261.
   PubMed Web of Science ®Google Scholar
• Thiel J, Kimmig L, Salzer U, et al. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol. 2012;129(3):801–10.e6.
   PubMed Web of Science ®Google Scholar
• Patuzzo G, Barbieri A, Tinazzi E, et al. Autoimmunity and infection in common variable immunodeficiency (CVID). Autoimmun Rev. 2016;15(9):877–882.
   PubMed Web of Science ®Google Scholar
• Isnardi I, Ng YS, Menard L, et al. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood. 2010;115(24):5026–5036.
   PubMed Web of Science ®Google Scholar
• Wehr C, Eibel H, Masilamani M, et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clinical Immunology (Orlando, Fla.). 2004;113(2):161–171.
   PubMed Web of Science ®Google Scholar
• Keller B, Strohmeier V, Harder I, et al. The expansion of human T-bethighCD21low B cells is T cell dependent. Science Immunology. 2021;6(64):eabh0891.
   PubMed Web of Science ®Google Scholar
• Rakhmanov M, Keller B, Gutenberger S, et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci U S A. 2009;106(32):13451–13456.
   PubMed Web of Science ®Google Scholar
• Abolhassani H, Amirkashani D, Parvaneh N, et al. Autoimmune phenotype in patients with common variable immunodeficiency. Journal of Investigational Allergology & Clinical Immunology. 2013;23(5):323–329.
   PubMed Web of Science ®Google Scholar
• Boileau J, Mouillot G, Gérard L, et al. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. Journal of Autoimmunity. 2011;36(1):25–32.
   PubMed Web of Science ®Google Scholar
• Vlkova M, Ticha O, Nechvatalova J, et al. Regulatory B cells in CVID patients fail to suppress multifunctional IFN-γ+ TNF-α+ CD4+ T cells differentiation. Clinical Immunology (Orlando, Fla.). 2015;160(2):292–300.
   PubMed Web of Science ®Google Scholar
• Barsotti NS, Almeida RR, Costa PR, et al. IL-10-producing regulatory B cells are decreased in patients with common variable immunodeficiency. PloS one. 2016;11(3):e0151761.
   PubMed Web of Science ®Google Scholar
• Kofod-Olsen E, Jørgensen SE, Nissen SK, et al. Altered fraction of regulatory B and T cells is correlated with autoimmune phenomena and splenomegaly in patients with CVID. Clinical Immunology (Orlando, Fla.). 2016;162:49–57.
   PubMed Web of Science ®Google Scholar
• Meyers G, Y-S N, Bannock JM, et al. Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(28):11554–11559.
   PubMed Web of Science ®Google Scholar
• Mackay F, Woodcock SA, Lawton P, et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. The Journal of Experimental Medicine. 1999;190(11):1697–1710.
   PubMed Web of Science ®Google Scholar
• Thien M, Phan TG, Gardam S, et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 2004;20(6):785–798.
   PubMed Web of Science ®Google Scholar
• Kreuzaler M, Rauch M, Salzer U, et al. Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors. Journal of Immunology (Baltimore, Md. : 1950). 2012;188(1):497–503.
   PubMed Web of Science ®Google Scholar
• Warnatz K, Voll R. Pathogenesis of autoimmunity in common variable immunodeficiency. Frontiers in Immunology. 2012;3(210).
   PubMedGoogle Scholar
• Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol. 2003;4(3):261–268.
   PubMed Web of Science ®Google Scholar
• Lee WI, Torgerson TR, Schumacher MJ, et al. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005;105(5):1881–1890.
   PubMed Web of Science ®Google Scholar
• Azizi G, Rezaei N, Kiaee F, et al. T-cell abnormalities in common variable immunodeficiency. Journal of Investigational Allergology & Clinical Immunology. 2016;26(4):233–243.
   PubMed Web of Science ®Google Scholar
• Bayry J, Hermine O, Webster DA, et al. Common variable immunodeficiency: the immune system in chaos. Trends Mol Med. 2005;11(8):370–376.
   PubMed Web of Science ®Google Scholar
• Boncristiano M, Majolini MB, D’Elios MM, et al. Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects. Eur J Immunol. 2000;30(9):2632–2638.
   PubMed Web of Science ®Google Scholar
• Di Renzo M, Zhou Z, George I, et al. Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): role of defective CD28 co-stimulation. Clin Exp Immunol. 2000;120(3):503–511.
   PubMed Web of Science ®Google Scholar
• Isgrò A, Marziali M, Mezzaroma I, et al. Bone marrow clonogenic capability, cytokine production, and thymic output in patients with common variable immunodeficiency. J Iimmunol. 2005;174(8):5074–5081. Baltimore, Md: 1950.
   PubMed Web of Science ®Google Scholar
• Rezaei N, Aghamohammadi A, Kardar GA, et al. T- helper 1 and 2 cytokine assay in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2008;18(6):449–453.
   PubMed Web of Science ®Google Scholar
• Rezaei N, Aghamohammadi A, Mahmoudi M, et al. Association of IL-4 and IL-10 gene promoter polymorphisms with common variable immunodeficiency. Immunobiology. 2010;215(1):81–87.
   PubMed Web of Science ®Google Scholar
• Rezaei N, Aghamohammadi A, Shakiba Y, et al. Cytokine gene polymorphisms in common variable immunodeficiency. Int Arch Allergy Immunol. 2009;150(1):1–7.
   PubMed Web of Science ®Google Scholar
• Rezaei N, Amirzargar AA, Shakiba Y, et al. Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol. 2009;155(1):21–27.
   PubMed Web of Science ®Google Scholar
• Bateman EAL, Ayers L, Sadler R, et al. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol. 2012;170(2):202–211.
   PubMed Web of Science ®Google Scholar
• Varzaneh FN, Keller B, Unger S, et al. Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge. J Clin Immunol. 2014;34(5):524–543.
   PubMed Web of Science ®Google Scholar
• Wong GK, Huissoon AP. T-cell abnormalities in common variable immunodeficiency: the hidden defect. J Clin Pathol. 2016;69(8):672.
   PubMed Web of Science ®Google Scholar
• Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12(6):492–499.
   PubMed Web of Science ®Google Scholar
• Aukrust P, Aandahl EM, Skålhegg BS, et al. Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency. J Iimmunol. 1999;162(2):1178–1185. Baltimore, Md: 1950.
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C, Bodian C, Ochs HD, et al. Long-term low-dose IL-2 enhances immune function in common variable immunodeficiency. Clin Immunol. 2001;100(2):181–190.
   PubMed Web of Science ®Google Scholar
• West EE, Jin HT, Rasheed AU, et al. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. J Clin Invest. 2013;123(6):2604–2615.
   PubMed Web of Science ®Google Scholar
• Perreau M, Vigano S, Bellanger F, et al. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J Exp Med. 2014;211(10):2033–2045.
   PubMed Web of Science ®Google Scholar
• Viallard JF, Blanco P, André M, et al. CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation. Clin Immunol. 2006;119(1):51–58.
   PubMed Web of Science ®Google Scholar
• Genre J, Errante PR, Kokron CM, et al. Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: a link to autoimmunity? Clin Immunol. 2009;132(2):215–221.
   PubMed Web of Science ®Google Scholar
• Yu GP, Chiang D, Song SJ, et al. Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease. Clin Immunol. 2009;131(2):240–253.
   PubMed Web of Science ®Google Scholar
• Fevang B, Yndestad A, Sandberg WJ, et al. Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo. Clin Exp Immunol. 2007;147(3):521–525.
   PubMed Web of Science ®Google Scholar
• Carvalho KI, Melo KM, Bruno FR, et al. Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID). PloS one. 2010;5(9):e12652.
   PubMed Web of Science ®Google Scholar
• Cowan JE, Jenkinson WE, Anderson G. Thymus medulla fosters generation of natural Treg cells, invariant γδ T cells, and invariant NKT cells: what we learn from intrathymic migration. Eur J Immunol. 2015;45(3):652–660.
   PubMed Web of Science ®Google Scholar
• Fulcher D, Avery D, Fewings N, et al. Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiency. Clinical and Experimental Immunology. 2009;157(3):365–369.
   PubMed Web of Science ®Google Scholar
• Gao Y, Workman S, Gadola S, et al. Common variable immunodeficiency is associated with a functional deficiency of invariant natural killer T cells. J Allergy Clin Immunol. 2014;133(5):1420–8.e1.
   PubMed Web of Science ®Google Scholar
• Juno JA, Keynan Y, Fowke KR. Invariant NKT cells: regulation and function during viral infection. PLoS Pathog. 2012;8(8):e1002838.
   PubMed Web of Science ®Google Scholar
• Li J, Jørgensen SF, Maggadottir SM, et al. Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells. Nat Commun. 2015;6:6804.
   PubMed Web of Science ®Google Scholar
• Zhang L, Radigan L, Salzer U, et al. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol. 2007;120(5):1178–1185.
   PubMed Web of Science ®Google Scholar
• Giovannetti A, Pierdominici M, Mazzetta F, et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol. 2007;178(6):3932.
   PubMed Web of Science ®Google Scholar
• Rezaei N, Wing JB, Aghamohammadi A, et al. B-cell–T-cell activation and interaction in common variable immunodeficiency. Hum Immunol. 2010;71(4):355–362.
   PubMed Web of Science ®Google Scholar
• Mouillot G, Carmagnat M, Gérard L, et al. B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. Journal of Clinical Immunology. 2010;30(5):746–755.
   PubMed Web of Science ®Google Scholar
• Romberg N, Le Coz C, Glauzy S, et al. Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses. The Journal of Allergy and Clinical Immunology. 2019;143(1):258–265.
   PubMed Web of Science ®Google Scholar
• Unger S, Seidl M, van Schouwenburg P, et al. The TH1 phenotype of follicular helper T cells indicates an IFN-γ–associated immune dysregulation in patients with CD21low common variable immunodeficiency. The Journal of Allergy and Clinical Immunology. 2018;141(2):730–740.
   PubMed Web of Science ®Google Scholar
• Kutukculer N, Azarsiz E, Aksu G, et al. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency. Int J Immunopathol Pharmacol. 2016;29(2):241–251.
   PubMed Web of Science ®Google Scholar
• Kralovicova J, Hammarström L, Plebani A, et al. Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. Journal of Immunology (Baltimore, Md. : 1950). 2003;170(5):2765–2775.
   PubMed Web of Science ®Google Scholar
• Aspalter RM, Sewell WAC, Dolman K, et al. Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin Exp Immunol. 2000;121(3):506–514.
   PubMed Web of Science ®Google Scholar
• Ebbo M, Gérard L, Carpentier S, et al. Low circulating natural killer cell counts are associated with severe disease in patients with common variable immunodeficiency. EBioMedicine. 2016;6:222–230.
   PubMed Web of Science ®Google Scholar
• Au-Yeung BB, Fowell D. A key role for Itk in both IFNγ and IL-4 production by NKT cells. Journal of Immunology (Baltimore, Md. : 1950). 2007;179(1):111–119.
   PubMed Web of Science ®Google Scholar
• Kronenber M. Toward an understanding of NKT cell biology: progress and paradoxes. Ann review of immunol. 2005;26:877–900.
   Google Scholar
• Falcone M, Facciotti F, Ghidoli N, et al. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. Journal of Immunology (Baltimore, Md. : 1950). 2004;172(10):5908–5916.
   PubMed Web of Science ®Google Scholar
• Oishi Y, Sumida T, Sakamoto A, et al. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus. J Rheumatol. 2001;28(2):275.
   PubMed Web of Science ®Google Scholar
• Snyder-Cappione JE, Nixon DF, Loo CP, et al. Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells. The Journal of Infectious Diseases. 2007;195(9):1361–1364.
   PubMed Web of Science ®Google Scholar
• Yanagihara Y, Shiozawa K, Takai M, et al. Immunology e. Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA). Clinical and Experimental Immunology. 1999;118(1):131.
   PubMed Web of Science ®Google Scholar
• Berzins SP, Cochrane AD, Pellicci DG, et al. Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples. European Journal of Immunology. 2005;35(5):1399–1407.
   PubMed Web of Science ®Google Scholar
• Nonoyama S, Farrington M, Ishida H, et al. Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin. The Journal of Clinical Investigation. 1993;92(3):1282–1287.
   PubMed Web of Science ®Google Scholar
• Stewart DM, McAvoy MJ, Hilbert DM, et al. B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro. Clinical Immunology (Orlando, Fla.). 2003;109(2):137–143.
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C, LJCi R. Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clinical Immunology (Orlando, Fla.). 2005;115(2):147–153.
   PubMed Web of Science ®Google Scholar
• He B, Santamaria R, Xu W, et al. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nature Immunology. 2010;11(9):836–845.
   PubMed Web of Science ®Google Scholar
• Treml LS, Carlesso G, Hoek KL, et al. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. Journal of Immunology (Baltimore, Md. : 1950). 2007;178(12):7531–7539.
   PubMed Web of Science ®Google Scholar
• Joyce EY, Zhang L, Radigan L, et al. TLR-mediated B cell defects and IFN-α in common variable immunodeficiency. J Clin Immunol. 2012;32(1):50–60.
   PubMed Web of Science ®Google Scholar
• Yu JE, Knight AK, Radigan L, et al. Toll-like receptor 7 and 9 defects in common variable immunodeficiency. J Allergy Clin Immunol. 2009;124(2):349–56.e3.
   PubMed Web of Science ®Google Scholar
• Bayry J, Lacroix-Desmazes S, Kazatchkine MD, et al. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood. 2004;104(8):2441–2443.
   PubMed Web of Science ®Google Scholar
• Viallard J-F, Camou F, André M, et al. Altered dendritic cell distribution in patients with common variable immunodeficiency. Arthritis Res Ther. 2005;7(5):R1052.
   PubMed Web of Science ®Google Scholar
• Aukkust P, MÜLler F, Frøland SS. Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency. Clin Exp Immunol. 1994;97(2):232–238.
   PubMed Web of Science ®Google Scholar
• Aukrust P, Lien E, Kristoffersen AK, et al. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency–possible immunologic and clinical consequences. Blood. 1996;87(2):674–681.
   PubMed Web of Science ®Google Scholar
• Cambronero R, Sewell WC, North ME, et al. Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency. Journal of Immunology (Baltimore, Md. : 1950). 2000;164(1):488–494.
   PubMed Web of Science ®Google Scholar
• Mullighan CG, Fanning GC, Chapel HM, et al. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. Journal of Immunology (Baltimore, Md. : 1950). 1997;159(12):6236–6241.
   PubMed Web of Science ®Google Scholar
• Amoras A, Kanegane H, Miyawaki T. Vilela MJJoia, immunology c. Defective Fc-, CR1-and CR3-mediated monocyte phagocytosis and chemotaxis in common variable immunodeficiency and X-linked agammaglobulinemia patients. Journal of Investigational Allergology & Clinical Immunology. 2003;13(3):181–188.
   PubMed Web of Science ®Google Scholar
• Eibl MM, Mannhalter JW, Zlabinger G, et al. Defective macrophage function in a patient with common variable immunodeficiency. The New England Journal of Medicine. 1982;307(13):803–806.
   PubMed Web of Science ®Google Scholar
• Mechanic LJ, Dikman S, Cunnigham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med. 1997;127(8_Part_1):613–617.
   PubMed Web of Science ®Google Scholar
• Casulli S, Coignard-Biehler H, Amazzough K, et al. Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency. Immunologic Research. 2014;60(1):69–76.
   PubMed Web of Science ®Google Scholar
• Casanova J-L, Conley ME, Seligman SJ, et al. Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. The Journal of Experimental Medicine. 2014;211(11):2137–2149.
   PubMed Web of Science ®Google Scholar
• Maffucci P, Filion CA, Boisson B, et al. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Frontiers in Immunology. 2016;7(220).
   PubMedGoogle Scholar
• Wehr C, Houet L, Unger S, et al. Altered spectrum of lymphoid neoplasms in a single-center cohort of common variable immunodeficiency with immune dysregulation. Journal of Clinical Immunology. 2021;41(6):1250–1265.
   PubMed Web of Science ®Google Scholar
• Quinti I, Soresina A, Guerra A, et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol. 2011;31(3):315–322.
   PubMed Web of Science ®Google Scholar
• Fischer A, Provot J, Jais J-P, et al. Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies. The Journal of Allergy and Clinical Immunology. 2017;140(5):1388–93. e8.
   PubMed Web of Science ®Google Scholar
• Resnick ES, Moshier EL, Godbold JH, et al. Morbidity and mortality in common variable immune deficiency over 4 decades. The Journal of the American Society of Hematology. 2012;119(7):1650–1657.
   Google Scholar
• H-e H, Cunningham-Rundles C. Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis. Frontiers in Immunology. 2020;11(149).
   Google Scholar
• Mormile I, Punziano A, Riolo CA, et al. Common variable immunodeficiency and autoimmune diseases: a retrospective study of 95 adult patients in a single tertiary care center. Front Immunol. 2021;12:2608.
   Web of Science ®Google Scholar
• Xiao X, Miao Q, Chang C, et al. Common variable immunodeficiency and autoimmunity – an inconvenient truth. Autoimmun Rev. 2014;13(8):858–864.
   PubMed Web of Science ®Google Scholar
• Mrusek S, Marx A, Kummerle-Deschner J, et al. Development of granulomatous common variable immunodeficiency subsequent to infection with Toxoplasma gondii. Clin Exp Immunol. 2004;137(3):578–583.
   PubMed Web of Science ®Google Scholar
• Marashi SM, Raeiszadeh M, Workman S, et al. Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus. J Allergy Clin Immunol. 2011;127(6):1385–93.e4.
   PubMed Web of Science ®Google Scholar
• Dolcino M, Puccetti A, Barbieri A, et al. Infections and autoimmunity: role of human cytomegalovirus in autoimmune endothelial cell damage. Lupus. 2015;24(4–5):419–432.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang H, Chen P, et al. Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods. Clinical Rheumatology. 2015;34(4):691–698.
   PubMed Web of Science ®Google Scholar
• Rider J, Ollier W, Lock R, et al. Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol. 1997;15(4):405–409.
   PubMed Web of Science ®Google Scholar
• Tsai Y-T, Chiang B-L, Kao Y-F, et al. Immunology, Detection of Epstein-Barr virus and cytomegalovirus genome in white blood cells from patients with juvenile rheumatoid arthritis and childhood systemic lupus erythematosus. International Archives of Allergy and Immunology. 1995;106(3):235–240.
   PubMed Web of Science ®Google Scholar
• Xu X, Estekizadeh A, Davoudi B, et al. Detection of human cytomegalovirus in synovial neutrophils obtained from patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology. 2021;50(3):183–188.
   PubMed Web of Science ®Google Scholar
• Lunardi C, Dolcino M, Peterlana D, et al. Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach. PLoS medicine. 2006;3(1):e2.
   PubMed Web of Science ®Google Scholar
• Randone SB, Guiducci S, Mmjar C. Systemic sclerosis and infections. Autoimmunity Reviews. 2008;8(1):36–40.
   PubMed Web of Science ®Google Scholar
• Arumugakani G, Wood PM, CRJJoci C. Frequency of Treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21 lo B lymphocytes. Journal of Clinical Immunology. 2010;30(2):292–300.
   PubMed Web of Science ®Google Scholar
• Park J, Shcherbina A, Rosen F, et al. Phenotypic perturbation of B cells in the Wiskott–Aldrich syndrome. Clinical and Experimental Immunology. 2005;139(2):297–305.
   PubMed Web of Science ®Google Scholar
• Chen K, Coonrod EM, Kumánovics A, et al. Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency. American Journal of Human Genetics. 2013;93(5):812–824.
   PubMed Web of Science ®Google Scholar
• Lucas CL, Kuehn HS, Zhao F, et al. Dominant-activating germline mutations in the gene encoding the PI (3) K catalytic subunit p110δ result in T cell senescence and human immunodeficiency. Nature Immunology. 2014;15(1):88–97.
   PubMed Web of Science ®Google Scholar
• Schwab C, Gabrysch A, Olbrich P, et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects. The Journal of Allergy and Clinical Immunology. 2018;142(6):1932–1946.
   PubMed Web of Science ®Google Scholar
• Tuijnenburg P, Allen HL, Burns SO, et al. Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. The Journal of Allergy and Clinical Immunology. 2018;142(4):1285–1296.
   PubMed Web of Science ®Google Scholar
• Milito C, Soccodato V, Auria S, et al. COVID-19 in complex common variable immunodeficiency patients affected by lung diseases. Curr Opin Allergy Clin Immunol. 2021;21(6):535–544.
   PubMed Web of Science ®Google Scholar
• Weifenbach N, Jung A, Lötters SJI. Inflammation,Disease. COVID‐19 infection in CVID patients: what we know so far. Immunity, Inflammation and Disease. 2021;9(3):632–634.
   PubMed Web of Science ®Google Scholar
• Jones JM, Faruqi AJ, Sullivan JK, et al. Immunity. COVID-19 outcomes in patients undergoing B cell depletion therapy and those with humoral immunodeficiency states: a scoping review. Pathogens & Immunity. 2021;6(1):76.
   PubMedGoogle Scholar
• Corse T, Dayan L, Kersten S, et al. Clinical outcomes of COVID-19 patients with pre-existing, compromised immune systems: a review of case reports. International Journal of Medical Sciences. 2020;17(18):2974.
   PubMed Web of Science ®Google Scholar
• Meyts I, Bucciol G, Quinti I, et al. Coronavirus disease 2019 in patients with inborn errors of immunity: an international study. The Journal of Allergy and Clinical Immunology. 2021;147(2):520–531.
   PubMed Web of Science ®Google Scholar
• Fernando SL, Jang HS, Jjil L. The immune dysregulation of common variable immunodeficiency disorders. Immunology Letters. 2021;230:21–26.
   PubMed Web of Science ®Google Scholar
• Janeway CA, Apt L, Gitlin D. Agammaglobulinemia. Trans Assoc Am Physicians. 1953;66:200–202.
   PubMedGoogle Scholar
• Cunningham-Rundles C. Immune deficiency: office evaluation and treatment. Allergy Asthma Proc. 2003;24(6):409–415.
   PubMed Web of Science ®Google Scholar
• Tam JS, Routes JM. Common Variable Immunodeficiency. Am J Rhinol Allergy. 2013;27(4):260–265.
   PubMed Web of Science ®Google Scholar
• Jaffe EF, Lejtenyi MC, Noya FJ, et al. America acoN. Secondary hypogammaglobulinemia. 2001;21(1):141–163.
   Google Scholar
• Lack G, Ochs HD, EWJTJop G. Humoral immunity in steroid-dependent children with asthma and hypogammaglobulinemia. The Journal of Pediatrics. 1996;129(6):898–903.
   PubMed Web of Science ®Google Scholar
• Eroglu FK, Aerts Kaya F, Cagdas D, et al. B lymphocyte subsets and outcomes in patients with an initial diagnosis of transient hypogammaglobulinemia of infancy. Scand J Immunol. 2018;88(4):e12709.
   PubMed Web of Science ®Google Scholar
• Justiz Vaillant AA, Wilson AM. Transient hypogammaglobulinemia of Infancy. StatPearls. Treasure Island (FL): StatPearls PublishingCopyright © 2022, StatPearls Publishing LLC; 2022.
   Google Scholar
• Abolhassani H, Rezaei N, Mohammadinejad P, et al. Important differences in the diagnostic spectrum of primary immunodeficiency in adults versus children. Expert Review of Clinical Immunology. 2015;11(2):289–302.
   PubMed Web of Science ®Google Scholar
• Subbarayan A, Colarusso G, Hughes SM, et al. Clinical features that identify children with primary immunodeficiency diseases. Pediatrics. 2011;127(5):810–816.
   PubMed Web of Science ®Google Scholar
• Azizi G, Abolhassani H, Habibi S, et al. Two faces of LRBA deficiency in siblings: hypogammaglobulinemia and normal immunoglobulin levels. Journal of Investigational Allergology & Clinical Immunology. 2018;28(1):48–50.
   PubMed Web of Science ®Google Scholar
• Reust CE. Evaluation of primary immunodeficiency disease in children. Am Fam Physician. 2013;87(11):773–778.
   PubMed Web of Science ®Google Scholar
• de Vries E, Driessen G. Educational paper: primary immunodeficiencies in children: a diagnostic challenge. Eur J Pediatr. 2011;170(2):169–177.
   PubMedGoogle Scholar
• Clutterbuck EA, Oh S, Hamaluba M, et al. Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine. Clinical and Vaccine Immunology : CVI. 2008;15(2):182–193.
   PubMedGoogle Scholar
• Yazdani R, Habibi S, Sharifi L, et al. Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management. J Investig Allergol Clin Immunol. 2019;30(1):14–34.
   PubMed Web of Science ®Google Scholar
• Keller M, Glessner J, Resnick E, et al. Burden of copy number variation in common variable immunodeficiency. Clinical and Experimental Immunology. 2014;177(1):269–271.
   PubMed Web of Science ®Google Scholar
• Stray-Pedersen A, Sorte HS, Samarakoon P, et al. Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders. The Journal of Allergy and Clinical Immunology. 2017;139(1):232–245.
   PubMed Web of Science ®Google Scholar
• Rehm HL, Bale SJ, Bayrak-Toydemir P, et al. ACMG clinical laboratory standards for next-generation sequencing. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 2013;15(9):733–747.
   PubMed Web of Science ®Google Scholar
• Mousallem T, Urban TJ, McSweeney KM, et al. Clinical application of whole-genome sequencing in patients with primary immunodeficiency. The Journal of Allergy and Clinical Immunology. 2015;136(2):476–9. e6.
   PubMed Web of Science ®Google Scholar
• Perez EE, Orange JS, Bonilla F, et al. Update on the use of immunoglobulin in human disease: a review of evidence. The Journal of Allergy and Clinical Immunology. 2017;139(3):S1–S46.
   PubMed Web of Science ®Google Scholar
• Rizzi M, Neumann C, Fielding AK, et al. Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. The Journal of Allergy and Clinical Immunology. 2011;128(6):1371–4. e2.
   PubMed Web of Science ®Google Scholar
• Wehr C, Gennery AR, Lindemans C, et al. Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency. The Journal of Allergy and Clinical Immunology. 2015;135(4):988–97. e6.
   PubMed Web of Science ®Google Scholar
• Verma N, Burns SO, Walker LSK, et al. Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations. Clin Exp Immunol. 2017;190(1):1–7.
   PubMed Web of Science ®Google Scholar
• Uzel G, Karanovic D, Su H, et al. Management of cytopenias in CTLA4 haploinsufficiency using Abatacept and sirolimus. Blood. 2018;132:2409.
   Web of Science ®Google Scholar
• Lo B, Zhang K, Lu W, et al. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to Abatacept therapy. Science (New York, N.Y.). 2015;349(6246):436–440.
   PubMed Web of Science ®Google Scholar
• Buckley R, Wang E. M285 ADULT MALE WITH STAT3 GAIN-OF-FUNCTION MUTATION PREVIOUSLY DIAGNOSED AS COMMON VARIABLE IMMUNODEFICIENCY. Ann Allergy Asthma Immunol. 2019;123(5):S120.
   PubMed Web of Science ®Google Scholar
• Russell MA, Pigors M, Houssen ME, et al. A novel de novo activating mutation in STAT3 identified in a patient with common variable immunodeficiency (CVID). Clin Immunol. 2018;187:132–136.
   PubMed Web of Science ®Google Scholar
• López AL, Niemela J, Stoddard J, et al. STAT3 gain-of-function mutation in an adult patient. Medicina (B Aires). 2021;81(6):1065–1068.
   PubMed Web of Science ®Google Scholar
• Milner JD, Vogel TP, Forbes L, et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood. 2015;125(4):591–599.
   PubMed Web of Science ®Google Scholar
• Forbes LR, Vogel TP, Cooper MA, et al. Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. The Journal of Allergy and Clinical Immunology. 2018;142(5):1665–1669.
   PubMed Web of Science ®Google Scholar
• Elgizouli M, Lowe DM, Speckmann C, et al. Activating PI3Kδ mutations in a cohort of 669 patients with primary immunodeficiency. Clin Exp Immunol. 2016;183(2):221–229.
   PubMed Web of Science ®Google Scholar
• Maccari ME, Abolhassani H, Aghamohammadi A, et al. Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase δ syndrome: the European society for immunodeficiencies-activated phosphoinositide 3-kinase δ syndrome registry. Front Immunol. 2018;9:543.
   PubMed Web of Science ®Google Scholar
• Nunes-Santos CJ, Uzel G, SDJJoA R, et al. PI3K pathway defects leading to immunodeficiency and immune dysregulation. The Journal of Allergy and Clinical Immunology. 2019;143(5):1676–1687.
   PubMed Web of Science ®Google Scholar
• Rao VK, Webster S, Dalm VASH, et al. Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib. Blood. 2017;130(21):2307–2316.
   PubMed Web of Science ®Google Scholar
• Guffroy A, Mourot-Cottet R, Gérard L, et al. Neutropenia in patients with common variable immunodeficiency: a rare event associated with severe outcome. Journal of Clinical Immunology. 2017;37(7):715–726.
   PubMed Web of Science ®Google Scholar
• Michel M, Chanet V, Galicier L, et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine. 2004;83(4):254–263.
   PubMed Web of Science ®Google Scholar
• Salzer U, Warnatz K, Peter HH. Common variable immunodeficiency - an update. Arthritis Res Ther. 2012;14(5):223.
   PubMed Web of Science ®Google Scholar
• Azizi G, Abolhassani H, Asgardoon MH, et al. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Rev Clin Immunol. 2017;13(2):101–115.
   PubMed Web of Science ®Google Scholar
• Scheuerlein P, Pietsch L, Camacho-Ordonez N, et al. Is it safe to switch from intravenous immunoglobulin to subcutaneous immunoglobulin in patients with common variable immunodeficiency and autoimmune thrombocytopenia? Frontiers in Immunology. 2018;9:1656.
   PubMed Web of Science ®Google Scholar
• Gobert D, Bussel JB, Cunningham‐Rundles C, et al. Efficacy and safety of rituximab in common variable immunodeficiency‐associated immune cytopenias: a retrospective multicentre study on 33 patients. British Journal of Haematology. 2011;155(4):498–508.
   PubMed Web of Science ®Google Scholar
• Arays R, Goyal S, Kmjpm J. Common variable immunodeficiency, immune thrombocytopenia, rituximab and splenectomy: important considerations. Postgraduate Medicine. 2016;128(6):567–572.
   PubMed Web of Science ®Google Scholar
• Wong G, Goldacker S, Winterhalter C, et al. Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients. Clinical and Experimental Immunology. 2013;172(1):63–72.
   PubMed Web of Science ®Google Scholar
• Carrabba M, Barcellini W, GJJoci F. Use of thrombopoietin-receptor agonist in CVID-associated immune thrombocytopenia. Journal of Clinical Immunology. 2016;36(5):434–436.
   PubMed Web of Science ®Google Scholar
• Rizvi FS, Zainaldain H, Rafiemanesh H, et al. Autoimmunity in common variable immunodeficiency: a systematic review and meta-analysis. Expert Rev Clin Immunol. 2020;16(12):1227–1235.
   PubMed Web of Science ®Google Scholar
• Fernández-Castro M, Mellor-Pita S, Citores MJ, et al. Common variable immunodeficiency in systemic lupus erythematosus. Semin Arthritis Rheum. 2007;36(4):238–245.
   PubMed Web of Science ®Google Scholar
• Swierkot J, Lewandowicz-Uszynska A, Chlebicki A, et al. Rheumatoid arthritis in a patient with common variable immunodeficiency: difficulty in diagnosis and therapy. Clin Rheumatol. 2006;25(1):92–94.
   PubMed Web of Science ®Google Scholar
• Edeer-Karaca N, Gülez N, Aksu G, et al. Common variable immunodeficiency: familial inheritance and autoimmune manifestations in two siblings. Turk J Pediatr. 2010;52(1):89–93.
   PubMed Web of Science ®Google Scholar
• Yong PF, Aslam L, Karim MY, et al. Management of hypogammaglobulinaemia occurring in patients with systemic lupus erythematosus. Rheumatology. 2008;47(9):1400–1405. (Oxford, England).
   PubMed Web of Science ®Google Scholar
• Agarwal S, LJCg M. Hepatology. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 2013;11(9):1050–1063.
   PubMed Web of Science ®Google Scholar
• Gathmann B, Mahlaoui N, Gérard L, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):116–26.e11.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Smereka P, Harpaz N, et al. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflammatory Bowel Diseases. 2011;17(1):251–259.
   PubMed Web of Science ®Google Scholar
• Daniels JA, Lederman HM, Maitra A, et al. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. The American Journal of Surgical Pathology. 2007;31(12):1800–1812.
   PubMed Web of Science ®Google Scholar
• Pollock G, Sharma A, Gjacrj M. Autoimmune hepatitis in a patient with common variable immunodeficiency. ACG Case Rep J. 2020;7(11).
   PubMed Web of Science ®Google Scholar
• Fuss IJ, Friend J, Yang Z, et al. Nodular regenerative hyperplasia in common variable immunodeficiency. Journal of Clinical Immunology. 2013;33(4):748–758.
   PubMed Web of Science ®Google Scholar
• Daniels JA, Torbenson M, Vivekanandan P, et al. Hepatitis in common variable immunodeficiency. Human Pathology. 2009;40(4):484–488.
   PubMed Web of Science ®Google Scholar
• Song J, Lleo A, Yang GX, et al. Common Variable Immunodeficiency and Liver Involvement. Clin Rev Allergy Immunol. 2018;55(3):340–351.
   PubMed Web of Science ®Google Scholar
• Malamut G, Verkarre V, Suarez F, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. The American Journal of Gastroenterology. 2010;105(10):2262–2275.
   PubMed Web of Science ®Google Scholar
• Venhoff N, Emmerich F, Neagu M, et al. The role of HLA DQ2 and DQ8 in dissecting celiac-like disease in common variable immunodeficiency. Journal of Clinical Immunology. 2013;33(5):909–916.
   PubMed Web of Science ®Google Scholar
• Uzzan M, Ko HM, Mehandru S, et al. Gastrointestinal disorders associated with common variable immune deficiency (CVID) and chronic granulomatous disease (CGD). Current Gastroenterology Reports. 2016;18(4):17.
   PubMedGoogle Scholar
• Boland BS, Riedl MA, Valasek MA, et al. Vedolizumab in patients with common variable immune deficiency and gut inflammation. The American Journal of Gastroenterology. 2017;112(10):1621.
   PubMed Web of Science ®Google Scholar
• Vázquez-Morón JM, Pallarés-Manrique H, Martín-Suárez IJ, et al. Crohn’s-like disease in a patient with common variable immunodeficiency treated with azathioprine and Adalimumab. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2013;105(5):299–302.
   PubMed Web of Science ®Google Scholar
• Chua I, Standish R, Lear S, et al. Anti-tumour necrosis factor-α therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clinical and Experimental Immunology. 2007;150(2):306–311.
   PubMed Web of Science ®Google Scholar
• Martire B, Gentile A, Francavilla R, et al. Immunotoxicology. Successful treatment with cyclosporine A of HCV-driven chronic liver disease mimicking autoimmune hepatitis in a patient with common variable immunodeficiency. Immunopharmacology and Immunotoxicology. 2005;27(4):535–543.
   PubMed Web of Science ®Google Scholar
• Azzu V, Elias JE, Duckworth A, et al. Liver transplantation in adults with liver disease due to common variable immunodeficiency leads to early recurrent disease and poor outcome. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2018;24(2):171–181.
   PubMed Web of Science ®Google Scholar
• Arunachalam M, Sanzo M, Lotti T, et al. Societa Italiana di Dermatologia e Sifilografia. Common variable immunodeficiency in vitiligo. 2010;145(6):783–788.
   Google Scholar
• Zarezadeh Mehrabadi A, Aghamohamadi N, Abolhassani H, et al. Comprehensive assessment of skin disorders in patients with Common Variable Immunodeficiency (CVID). J Clin Immunol. 2022;42(3):653–664.
   PubMed Web of Science ®Google Scholar
• Prasse A, Kayser G, KJCoipm W. Common variable immunodeficiency-associated granulomatous and interstitial lung disease. Current Opinion in Pulmonary Medicine. 2013;19(5):503–509.
   PubMed Web of Science ®Google Scholar
• Park JH, Aijci L. Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID). Clinical Immunology (Orlando, Fla.). 2010;134(2):97–103.
   PubMed Web of Science ®Google Scholar
• Maglione PJ, Overbey JR, Cunningham-Rundles C. Progression of common variable immunodeficiency interstitial lung disease accompanies distinct pulmonary and laboratory findings. J Allergy Clin Immunol. 2015;3(6):941–950.
   Web of Science ®Google Scholar
• Patel S, Anzilotti C, Lucas M, et al. Interstitial lung disease in patients with common variable immunodeficiency disorders: several different pathologies? Clinical and Experimental Immunology. 2019;198(2):212–223.
   PubMed Web of Science ®Google Scholar
• Rao N, Mackinnon AC, JMJHp R. Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency—histologic and immunohistochemical analyses of 16 cases. Human Pathology. 2015;46(9):1306–1314.
   PubMed Web of Science ®Google Scholar
• Orange JS, Grossman WJ, Navickis RJ, et al. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clinical Immunology (Orlando, Fla.). 2010;137(1):21–30.
   PubMed Web of Science ®Google Scholar
• Milito C, Pulvirenti F, Cinetto F, et al. Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies. The Journal of Allergy and Clinical Immunology. 2019;144(2):584–93. e7.
   PubMed Web of Science ®Google Scholar
• Boursiquot J-N, Gérard L, Malphettes M, et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clinical Immunology. 2013;33(1):84–95.
   PubMed Web of Science ®Google Scholar
• Chase NM, Verbsky JW, Hintermeyer MK, et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). Journal of Clinical Immunology. 2013;33(1):30–39.
   PubMed Web of Science ®Google Scholar
• Verbsky JW, Hintermeyer MK, Simpson PM, et al. Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency. The Journal of Allergy and Clinical Immunology. 2021;147(2):704–12. e17.
   PubMed Web of Science ®Google Scholar
• Franxman TJ, Howe LE, JRJJoci B. Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency. Journal of Clinical Immunology. 2014;34(7):820–827.
   PubMed Web of Science ®Google Scholar